BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND STAT6, D12S1644, 6778, ENSG00000166888, IL-4-STAT, P42226, STAT6B, STAT6C
36 results:

  • 1. Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways.
    Ciummo SL; Sorrentino C; Fieni C; Di Carlo E
    J Exp Clin Cancer Res; 2023 Dec; 42(1):336. PubMed ID: 38087324
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6.
    Chen S; Lu K; Hou Y; You Z; Shu C; Wei X; Wu T; Shi N; Zhang G; Wu J; Chen S; Zhang L; Li W; Zhang D; Ju S; Chen M; Xu B
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37094986
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. STAT3 and Its Pathways' Dysregulation-Underestimated Role in Urological Tumors.
    Golus M; Bugajski P; Chorbińska J; Krajewski W; Lemiński A; Saczko J; Kulbacka J; Szydełko T; Małkiewicz B
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230984
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Solitary fibrous tumors in prostate: a case report with review of the literature.
    Peng Y; Jiang Y; Ding S; Zheng Y; Tang W; Liu J
    Aging Male; 2022 Dec; 25(1):219-227. PubMed ID: 35989611
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Machine Learning-based Virtual Screening for STAT3 Anticancer Drug Target.
    Wadood A; Ajmal A; Junaid M; Rehman AU; Uddin R; Azam SS; Khan AZ; Ali A
    Curr Pharm Des; 2022; 28(36):3023-3032. PubMed ID: 35909285
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. LXA4 enhances prostate cancer progression by facilitating M2 macrophage polarization via inhibition of METTL3.
    Jia G; Wang X; Wu W; Zhang Y; Chen S; Zhao J; Zhao W; Li W; Sun X; Han B
    Int Immunopharmacol; 2022 Jun; 107():108586. PubMed ID: 35228032
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mesenchymal Neoplasms of the prostate and Seminal Vesicles: Spectrum of Disease with Radiologic-Pathologic Correlation.
    Marcal LP; Surabhi VR; Ramani NS; Katabathina VS; Paspulati RM; Prasad SR
    Radiographics; 2022; 42(2):417-432. PubMed ID: 35030067
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Solitary Fibrous Tumor With Extensive Epithelial Inclusions.
    Zhao M; He H; Cao D; Fan D; Xu M; Zhang X; Ru G
    Am J Clin Pathol; 2022 Jul; 158(1):35-46. PubMed ID: 34999741
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. STEAP3 promotes cancer cell proliferation by facilitating nuclear trafficking of EGFR to enhance RAC1-ERK-STAT3 signaling in hepatocellular carcinoma.
    Wang LL; Luo J; He ZH; Liu YQ; Li HG; Xie D; Cai MY
    Cell Death Dis; 2021 Nov; 12(11):1052. PubMed ID: 34741044
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypes.
    Acosta AM; Sholl LM; Dickson BC; McKenney JK; Gordetsky JB; Pins MR; Marino-Enriquez A; Dong F; Dubuc AM; Cin PD; Fletcher CDM
    Mod Pathol; 2021 Sep; 34(9):1763-1779. PubMed ID: 33986460
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Primary solitary fibrous tumour of the prostate: A case report and literature review.
    Okubo Y; Nukada S; Shibata Y; Osaka K; Yoshioka E; Suzuki M; Washimi K; Kawachi K; Kishida T; Yokose T; Miyagi Y
    Malays J Pathol; 2020 Dec; 42(3):449-453. PubMed ID: 33361728
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinicopathological features to distinguish malignant solitary fibrous tumors of the prostate from prostatic stromal tumors.
    Xu Y; Li Z; Shi J; Fu Y; Zhu L; Fan X; Foo WC
    Virchows Arch; 2021 Apr; 478(4):619-626. PubMed ID: 32820389
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Malignant solitary fibrous tumour of the prostate: four cases emphasising significant histological and immunophenotypical overlap with sarcomatoid carcinoma.
    Bakhshwin A; Berry RS; Cox RM; Li R; Reynolds JP; Rubin BP; McKenney JK
    Pathology; 2020 Oct; 52(6):643-648. PubMed ID: 32758370
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Survival and prognostic determinants of prostate cancer patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
    Beksisa J; Getinet T; Tanie S; Diribi J; Hassen HY
    PLoS One; 2020; 15(3):e0229854. PubMed ID: 32134996
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. stat6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines.
    Salguero-Aranda C; Sancho-Mensat D; Canals-Lorente B; Sultan S; Reginald A; Chapman L
    PLoS One; 2019; 14(5):e0207558. PubMed ID: 31075146
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13-stimulated monocytes and A549 lung carcinoma cells.
    Dhabal S; Das P; Biswas P; Kumari P; Yakubenko VP; Kundu S; Cathcart MK; Kundu M; Biswas K; Bhattacharjee A
    J Biol Chem; 2018 Sep; 293(36):14040-14064. PubMed ID: 30021838
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A rare case of malignant solitary fibrous tumor in prostate with review of the literature.
    Ronchi A; La Mantia E; Gigantino V; Perdonà S; De Sio M; Facchini G; Franco R; De Chiara A
    Diagn Pathol; 2017 Jul; 12(1):50. PubMed ID: 28687087
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The utility of stat6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasms.
    Guner G; Bishop JA; Bezerra SM; Taheri D; Zahavi DJ; Mendoza Rodriguez MA; Sharma R; Epstein JI; Netto GJ
    Hum Pathol; 2016 Aug; 54():184-8. PubMed ID: 27068523
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Clinicopathologic features of solitary fibrous tumor in urogenital system].
    Ruan HJ; Huang AH; Cheng S; Fu GX
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):248-51. PubMed ID: 27033388
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing.
    Cieslik M; Chugh R; Wu YM; Wu M; Brennan C; Lonigro R; Su F; Wang R; Siddiqui J; Mehra R; Cao X; Lucas D; Chinnaiyan AM; Robinson D
    Genome Res; 2015 Sep; 25(9):1372-81. PubMed ID: 26253700
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.